Menu Search
Equities

Lifecare ASA

LIFE:OSL

Lifecare ASA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NOK)1.70
  • Today's Change-0.02 / -1.16%
  • Shares traded45.74k
  • 1 Year change-16.22%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in NOK

The one analyst offering a 12 month price target expects Lifecare ASA share price to rise to 3.60 in the next year from the last price of 1.70.
High111.8%3.60
Med111.8%3.60
Low111.8%3.60

Earnings history & estimates in NOK

On Aug 27, 2024, Lifecare ASA reported 2nd quarter 2024 losses of -0.09 per share. This result was in line with the expectation of the one analyst following the company and under-performed last year's 2nd quarter results by 55.17%.
The next earnings announcement is expected on Nov 21, 2024.
Average growth rate-16.69%
Lifecare ASA reported annual 2023 losses of -0.227 per share on Feb 27, 2024.
More ▼

Revenue history & estimates in NOK

Lifecare AS had 2nd quarter 2024 revenues of 6.44m. This bettered the 1.00m estimate of the one analyst covering the company. This was 146.61% above the prior year's 2nd quarter results.
Average growth rate+396.01%
Lifecare AS had revenues for the full year 2023 of 11.56m. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.